We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGRP
4526
DELISTED
SPAR Group
SGRP
$113K ﹤0.01%
79,437
+21,998
+38% +$34.9K
UFAB
4527
DELISTED
Unique Fabricating, Inc.
UFAB
$113K ﹤0.01%
30,623
+17,844
+140% +$74.2K
XNET
4528
Xunlei
XNET
$360M
$112K ﹤0.01%
24,694
+5,079
+26% +$26K
TCAC
4529
DELISTED
Tuatara Capital Acquisition Corporation Class A Ordinary Shares
TCAC
$112K ﹤0.01%
+11,671
New +$113K
JFU
4530
9F Inc
JFU
$23.7M
$111K ﹤0.01%
2,127
-1,021
-32% -$35.5K
TENX icon
4531
Tenax Therapeutics
TENX
$401M
$111K ﹤0.01%
32
-1
-3% -$3.17K
ID
4532
DELISTED
PARTS iD, Inc.
ID
$111K ﹤0.01%
+18,397
New +$126K
HCAQ
4533
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$111K ﹤0.01%
+11,300
New +$112K
CSPI icon
4534
CSP Inc
CSPI
$79.2M
$110K ﹤0.01%
20,730
TRVI icon
4535
Trevi Therapeutics
TRVI
$2.61B
$110K ﹤0.01%
49,077
RBCN
4536
DELISTED
Rubicon Technology, Inc.
RBCN
$110K ﹤0.01%
11,566
CEI
4537
DELISTED
Camber Energy, Inc
CEI
$109K ﹤0.01%
3,315
ARTW icon
4538
Arts-Way Manufacturing Co
ARTW
$11.3M
$108K ﹤0.01%
32,042
BSBK icon
4539
Bogota Financial
BSBK
$116M
$108K ﹤0.01%
10,653
-36,693
-77% -$368K
CXDO icon
4540
Crexendo
CXDO
$221M
$108K ﹤0.01%
17,766
+1,800
+11% +$10.3K
BNKK
4541
Bonk Inc
BNKK
$7.96M
$107K ﹤0.01%
687
+334
+95% +$52.2K
MTCR
4542
DELISTED
Metacrine, Inc. Common Stock
MTCR
$107K ﹤0.01%
28,254
-30,448
-52% -$126K
ENLC
4543
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$106K ﹤0.01%
16,655
+2,556
+18% +$13.1K
ENTX icon
4544
Entera Bio
ENTX
$145M
$105K ﹤0.01%
+17,597
New +$65.1K
OBIO icon
4545
Orchestra BioMed
OBIO
$239M
$105K ﹤0.01%
+10,388
New +$107K
ESSC
4546
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$105K ﹤0.01%
+10,409
New +$104K
FRSX
4547
Foresight Autonomous Holdings
FRSX
$3.81M
$104K ﹤0.01%
195
+18
+10% +$10.3K
UK icon
4548
Ucommune International Ltd Class A Ordinary Shares
UK
$1.42M
$104K ﹤0.01%
20
+4
+25% +$22.3K
BLIN icon
4549
Bridgeline Digital
BLIN
$14.7M
$103K ﹤0.01%
24,084
+9,309
+63% +$24.6K
XBIO icon
4550
Xenetic Biosciences
XBIO
$5.84M
$103K ﹤0.01%
5,051
+1,925
+62% +$38.8K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.